Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation Use in Refractory Glaucoma Patients

Elsa Gustianty, Andika Prahasta, R. Maula Rifada, Ludwig Melino Tjokrovonco


Glaucoma is the leading cause of irreversible blindness worldwide. Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) is a new method for treatment for refractory glaucoma with lesser complications than coventional TSCPC. This study aimed to evaluate the effectiveness and safety of MP-TSCPC (IRIDEX IQ810 Laser systems, CA) for refractory glaucoma treatment. This was a retrospective study using data obtained from the medical records of patients who underwent a MP-TSCPC procedure at Cicendo National Eye Hospital from July 2018 to September 2019. The outcomes measured were success rate (IOP decreased ≥30% from baseline with or without anti glaucoma medication at first month follow up) and post-operative complications. Fifty-seven eyes from 56 patients with a mean age of 57 years old underwent MP-TSCPC with 3 month follow up. The mean pre-operative intraocular pressure (IOP) dropped from 51.8 mmHg to 36.0 mmHg at 1 month follow up and 36.8 mmHg at the final follow up, representing an IOP decrease of 31% (1 month) and 28% (3 month). There was also a decrease of anti glaucoma medication usage from 2.51 to 2.16. The overall success rate at 1 month follow up was 49% and only 5% complication were found in this study. MP-TSCPC is safe and effective for lowering IOP and decreasing the need of anti glaucoma -medications in refractory glaucoma case. Further long-term evaluation and comparison to conventional TSCPC are still necessary.


Glaucoma, laser, micropulse transscleral cyclophotocoagulation

Full Text:



  1. International Agency for the Prevention of Blindness. Proceeding of Roadmap of Visual Impairment Control Program in Indonesia 2017-2030; 2019 October 7-8. Sea Regional Consultation Meeting. Bangkok: IAPB; 2019.
  2. Tham YC, Li X, Wong TY, Quiqley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. J Opthalmol. 2014;121(11):2081-90.
  3. Ishida K. Update on results and complications of cyclophotocoagu- lation. Curr Opin Opthalmol. 2013;24:102–10.
  4. Amoozgar B, Phan EN, Lin SC, Han Y. Update on ciliary body laser procedures. Curr Opin Opthalmol. 2017;28:181–6.
  5. Aquino MC, Barton K, Tan AM, Sng C, Li X, Loon SC, Chew PT. Micropulse versus continuous wave transscleral diode cyclophoto- coagulation in refractory glaucoma: a randomized exploratory study. Clin Experiment Opthalmol. 2015;43:40–6.
  6. Abdelrahman AM, El Sayed YM. Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma. J Glaucoma. 2018;27(10):900–5.
  7. Tan AM, Chockalingam M, Aquino MC, Lim ZL, See JL, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experimental Opthalmol. 2010;38:266–72.
  8. Toyos MM, Toyos R. Clinical outcomes of micropulsed transcleral cyclophotocoagulation in moderate to severe glaucoma. J clin Exp Opthalmol. 2016;7:6.
  9. Emanuel ME, Grover DS, Fellman RL, Godfrey DG, Smith O, Butler MR, et al. Micropulse Cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. 2017;26:726–9.
  10. Maslin J, Chen P, Noecker RJ, Sinard J, Nguyen AT. Comparison of acute histological changes in human cadaver eyes after micropulse and continuous wave transcleral cyclophotocoagulation. In: 26th Annual Meeting of American Glaucoma Society, 2016 March 3-6; Fort Lauderdale, Florida. USA: AGS; 2016. p. 330–5.
  11. Nguyen AT, Maslin J, and Noecker RJ. Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophthalmol.2019;2:1120672119839303.
  12. Johnstone M, Murray J. Transcleral laser induces aqueous outflow pathway motion & reorganization. AGS 2017; Coronado, CA 2017.
  13. Sanchez FG, Bonomi JC, Grippo TM. Micropulse transscleral cyclophotocoagulation: a hypothesis for ideal parameters. Med hypothesis Discov Innov Ophthalmol. 2018;7(3):94–100.
  14. Sanchez FG, Lerner FS, Sampaolesi J, Noecker R, Becerra N, Iribarren G, Grippo TM. Success rate of micropulse transscleral cyclophoto- coagulation in complex glaucoma based on variable treatment duration. Invest Ophthal Vis Sci, 2018;59(9):6107–8.
  15. Kuchar S, Moster MR, Reamer CB, et al. Treatment outcomes of micropulse transscleral cyclophoto- coagulation in advanced glaucoma. Laser Med Sci. 2016;31:393–6.
  16. Aquino M, Chew P. Long term efficacy of micropulse diode transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Laser Med Sci. 2017;43:40–6.
  17. Aquino M, Chew P. Proceeding of Early Outcomes of Micropulse Diode Transscleral Cyclophototherapy for the Treatment of Mild to Moderate Glaucoma; 2017 November 18; Korea. Korean Glaucoma Society Annual Meeting; 2017.
  18. Nguyen M, Noecker M. Micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. In: 27th Annual American Glaucoma Society Meeting; 2017 March 2-5; Coronado, California. USA: AGS; 2017. p. 320–5.
  19. Lee J and Lin S. Outcomes of micropulse laser TSCPC on pediatric vs adult glaucoma patients. J Glaucoma. 2017;26:936–9.
  20. Sarrafpour S, Ayoub S, Radcliffe NM. Evaluating the long-term effects of micropulse cyclophotocoagulation on glaucoma patients. Invest Ophthal Vis Sci., 2018;59(9):6103–4.
  21. Williams AL, Moster MR, Rahmatnejad K, Resende AF, Horan T, Reynolds M, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophoto- coagulation in refractory glaucoma. J Glaucoma, 2018;27(5):445–9.
  22. Zhou D, Mas-Ramirez AM, Siegel MJ. Micropulse cyclophotocoagu- lation: Patients’ perceived pain score. Invest Ophthalmol Vis Sci, 2017;58(8):4994.
  23. Huang P, McKnight B, Akil H, Huang AS, Francis BA. Efficacy and safety of Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Invest Ophthalmol Vis Sci. 2017;58(8):4997.
  24. Patel K, Gelinas N, Rafay H, patrianakos t, Giovingo M. The effects of micropulse transscleral cyclophotocoagulation versus traditional transscleral cyclophoto- coagulation diode on intraocular pressure in primary open angle glaucoma. Invest Ophthalmol Vis Sci. 2017;58(8):4991.

DOI: https://doi.org/10.15395/mkb.v54n3.2648

Article Metrics

Abstract view : 442 times
PDF - 373 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


View My Stats